|
- 2016
培哚普利对慢性心力衰竭患者血浆miR-423-5p的调控及对心功能的影响
|
Abstract:
[1] | Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure[J]. Circ Res, 2010, 106(6): 1035-1039. |
[2] | Goren Y, Kushnir M, Zafrir B, et al. Serum levels of microRNAs in patients with heart failure[J]. Eur J Heart Fail, 2012, 14(2):147-154. |
[3] | Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297. |
[4] | Gidlof O, van der Brug M, Ohman J, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression[J]. Blood, 2013, 121(19): 3908-3917. |
[5] | Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure[J]. Cardiovasc Drugs Ther, 2011, 25(2): 171-182. |
[6] | Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure[J]. Circulation, 2007, 116(3): 258-267. |
[7] | Fan KL, Zhang HF, Shen J, et al. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy[J]. Indian Heart J, 2013, 65(1): 12-16. |
[8] | 陈东昌. 慢性心力衰竭患者血清miRNAs及血红素氧合酶-1的变化及意义[D]. 济南:山东大学, 2014. |
[9] | Group CM. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators[J]. N Engl J Med, 1991, 325(5): 293-302. |
[10] | 李黎, 张丽华, 李凌, 等. 阿托伐他汀对心肌梗死大鼠心室重构和miRNA-21表达的影响[J]. 郑州大学学报(医学版), 2015, 50(4): 488-492. LI Li, ZHANG Lihua, LI Ling, et al. Effect of atorvastatin on ventricular remodeling and expression of miRNA-21 in rats with myocardial infarction[J]. Journal of Zhengzhou University(Medical Sciences), 2015, 50(4): 488-492. |
[11] | Besser J, Malan D, Wystub K, et al. MiRNA-1/133a clusters regulate adrenergic control of cardiac repolarization[J]. PLoS One, 2014, 9(11): e113449. doi: 10.1371/journal.pone.0113449. |
[12] | Neilson JR, Zheng GX, Burge CB, et al. Dynamic regulation of miRNA expression in ordered stages of cellular development[J]. Genes Dev, 2007, 21(5): 578-589. |
[13] | Dickinson BA, Semus HM, Montgomery RL, et al. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure[J]. Eur J Heart Fail, 2013, 15(6): 650-659. |
[14] | 谈红, 李艳敏, 张红明, 等. 慢性充血性心力衰竭患者血浆miR-423-5p和miR-210-3p的表达变化[J]. 临床心血管病杂志, 2014, 30(12): 1081-1085. TAN Hong, LI Yanmin, ZHANG Hongming, et al. The expression changes of plasma miR-423-5p and miR-210-3p in patients with chronic heart failure[J]. Journal of Clinical Cardiology, 2014, 30(12): 1081-1085. |
[15] | Song HM, Zhang J, Deng B, et al. Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure[J]. Chinese Medical Journal, 2005, 85(25): 1737-1740. |
[16] | 谈红, 王雪, 李晓燕, 等. 培哚普利对冠心病患者循环血内皮祖细胞及血管内皮功能的影响[J]. 中国循环杂志, 2015, 30(1): 22-25. TAN Hong, WANG Xue, LI Xiaoyan, et al. Effect of different doses of perindopril on endothelial progenitor cells and vascular endothelial function in patients with coronary artery disease[J]. Chinese Circulation Journal, 2015, 30(1): 22-25. |
[17] | Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000, 342(3): 145-153. |
[18] | 谈红, 陈瑞敏, 李晓燕, 等. 瑞舒伐他汀对急性冠脉综合征患者CD4+T淋巴细胞miRNA表达的影响[J]. 解放军医学杂志, 2014, 39(2): 99-104. TAN Hong, CHEN Ruimin, LI Xiaoyan, et al. Differences of CD4+T lymphocyte miRNA gene expression in acute coronary artery syndrome(ACS)patients and the effects of rosuvastatin on its expressions[J]. Medical Journal of Chinese Peoples Liberation Army, 2014, 39(2): 99-104. |